HUPO 2022 World Congress

#HUPO 2022 Starts December 4, 2022

HUPO 2022 Speakers

Get to Know the Speakers

Meet the speakers for the HUPO 2022. In order to learn more about each individual speaker, please click on the photos below.

Main Congress Speakers

Steve Pennington

Categories: Award Winners, Main Congress Speakers
Steve Pennington: Ireland

Steve is Professor of Proteomics at the UCD School of Medicine & Conway Institute in Dublin, Ireland. He graduated from Imperial College, London (Chemistry and Biochemistry) before completing a PhD in Biochemistry at the University of Cambridge. He was elected President of HUPO (www.hupo.org) (2019-2021) and recently received HUPO’s biennial distinguished service award. He is also the founder of the UCD spin out company Atturos (www.atturos.com).

Steve Pennington

Click To Read Bio

Prof. Ying Ge

Categories: Award Winners, Main Congress Speakers
Prof. Ying Ge: USA

Dr. Ying Ge is a Professor in the Department of Cell and Regenerative Biology and Department of Chemistry at University of Wisconsin-Madison. She received a B.S. from Peking University and a Ph.D. from Cornell University under the joint supervision of Prof. Fred McLafferty and Prof. Tadhg Begley. After graduate school, Dr. Ge explored a career in pharmaceutical industry. In 2012, Dr. Ge started her tenure-track Assistant Professor position, received tenure in 2015, and was promoted to Full Professor in 2019. Ge’s research is highly interdisciplinary that cuts across the traditional boundaries of chemistry, biology, and medicine. It is her belief that to make significant impact in molecular medicine, it is necessary to combine technology with function and bridge the silos between basic and translational/clinical research for precision medicine. Dr. Ge has devoted her past twenty years to developing and applying top-down mass spectrometry-based proteomics to biomedical research. Recently her lab has developed a multi-pronged approach to address the challenges in top-down proteomics. Dr. Ge has published over 150 papers with many in high impact journals. She has received a number of awards such as the ASMS Biemann Medal (2020), HUPO Clinical and Translational Proteomics Award (2021), and HPLC Society Georges Guiochon Faculty Fellowship (2016), as well as The Top 100 Analytical Scientist Power List (on a global scale, 2019, 2020 2021). Dr. Ge is passionate about education and has been mentoring students from chemistry, biology and medicine.

Prof. Ying Ge

Click To Read Bio

Prof. Tadashi Yamamoto

Categories: Award Winners, Main Congress Speakers
Prof. Tadashi Yamamoto: Japan
Prof. Tadashi YAMAMOTO, the project leader of the Biofluid Biomarker Center (BBC), is a pioneer of proteomics of kidney diseases and urine biomarker discovery after engaging in the HUPO Human Kidney & Urine Proteome Project (HKUPP) in 2005. During his HKUPP chairmanship he introduced proteomics in nephrology and provided proteomics information in nephrology through the HKUPP website. He and BBC group have developed the protocols for proteomics of formalin-fixed paraffin-embedded human kidney biopsy tissues to understand pathophysiology of kidney diseases and of urine to discover biomarkers of kidney and urinary tract diseases by providing a standard guide for urine collection, and urine and kidney tissue proteome databases. Recently the biomarker discovery has been extended to all human diseases In collaboration with Tosoh Corporation by collecting more than 100,000 urine samples from patients with any diseases. He and his group have established a standard protocol for urine quantitative proteomics to measure approximately 2,000 urine proteins quantitatively for discovery of urine biomarkers of all human diseases. His goal is to provide a healthcare system, called “All-in-One Urine Tests”, to people for easy checkup of health conditions and early detection of diseases only by urine examination at home or office.

Prof. Tadashi Yamamoto

Click To Read Bio

Prof. Fuchu He

Categories: Award Winners, Main Congress Speakers
Prof. Fuchu He: China

Dr. He is the leading scientist studying proteomics in China. He was the founder of CNHUPO and among the first group of people who founded HUPO in 2001. He was the first Chinese scientist who led an international consortium-Human Liver Proteome Project (HLPP), and the founder of Beijing Proteome Research Center, Phoenix Center (proteomics) and Institutes of Biomedical Sciences Fudan University. As the chief scientist, he has been propelling HLPP to the China Human Proteome Project (CNHPP), to create an encyclopedia of proteins in the human body under physiological and pathological conditions. In 2019, his team stratified early hepatocarcinoma (HCC) into 3 proteomic subtypes with different clinical outcome. Some drug targetable proteins have been demonstrated useful in identifying patients with HCC who could potentially benefit from targeted treatment in further clinical trials. These studies demonstrated the proteomic analysis as an independent powerful tool in cancer molecular subtyping, indicating that the era of “Proteomics Driven Precision Medicine (PDPM)” is coming. He is currently proposing a world-wide project called π-HuB (The Proteomic Navigator of the Human Body). It aims at playing a central and catalytic role in biomedical research over the next several decades and providing an ultimate solution at the molecular level for health and well-being of the humankind.

Prof. Fuchu He

Click To Read Bio

Prof. Benjamin Garcia

Categories: Award Winners, Main Congress Speakers
Prof. Benjamin Garcia: USA

Benjamin A. Garcia obtained his BS in Chemistry at UC Davis in 2000, and then received his PhD in Chemistry in 2005 at the University of Virginia under Prof. Donald Hunt and then was an NIH NRSA Postdoctoral Fellow at the University of Illinois under Prof. Neil Kelleher from 2005-2008. From there Ben was appointed as an Assistant Professor in the Molecular Biology Department at Princeton University from 2008-2012, until his recruitment as the Presidential Associate Professor of Biochemistry and Biophysics at the University of Pennsylvania Perelman School of Medicine in 2012, promoted to full Professor in 2016, and named the John McCrea Dickson M.D. Presidential Professor in 2017. Ben moved in the summer of 2021 to the Washington University School of Medicine in St. Louis to become the Chair of the Department of Biochemistry and Molecular Biophysics. The Garcia lab has been developing and applying novel proteomic approaches and bioinformatics for interrogating protein modifications, especially those involved in epigenetic mechanisms such as histones during human disease, publishing over 350 publications. Ben has also been recognized with many honors and awards for his mass spectrometry research including The ASMS Biemann Medal and was named a Fellow of the Royal Society of Chemistry.

Prof. Benjamin Garcia

Click To Read Bio

Nickki Packer

Categories: Award Winners, Main Congress Speakers
Nickki Packer: Australia

Prof Nicki Packer has had an extensive and varied research career in both Chemistry and Biological Sciences. She helped establish the Australian Proteome Analysis Facility (APAF) and co-founded Proteome Systems Ltd, a biotechnology company in which her group developed glycoanalytical technology and informatics tools. She has gained national and international recognition for her research in glycomics, using proteomics and bioinformatics approaches and linking it to biological functional research. Her current research is in the structure, function, informatics and application of glycans and their conjugates as molecular markers, focusing on their role in cancer, therapeutics and microbial infection. Nicki currently holds positions as Distinguished Professor of Glycoproteomics, and is a Chief Investigator in two ARC Centres of Excellence (NanoScale BioPhotonics and Synthetic Biology), is Academic Lead of APAF at Macquarie University, Sydney, and is a Principal Research Leader at the Institute for Glycomics, Griffith University, Australia. Her research role in all her work is directed towards the role of protein glycosylation in health and disease; specifically her current projects encompass the analysis and role of glycosylation in many systems including the i) function of glycans attached to glycoproteins and glycolipids, ii) cell membrane glycosylation interactions, iii) glycans as targets for bioimaging, diagnosis and drugs, iv) the mucin glycome-microbiome interactions. She has also raised three (reasonably well-balanced) children…..

Nickki Packer

Click To Read Bio

Mr. Oliver Raether

Categories: Award Winners, Main Congress Speakers
Mr. Oliver Raether: USA
Oliver Raether studied automation, measurement, control and feedback control engineering, optical- and environmental measurement and obtained in 1995 his Master of Science Degree from the Hamburg University of Technology in Germany.
In the same year Oliver Raether took up a position at Bruker Daltonik in Bremen Germany developing mobile gas chromatography and portable quadrupole mass spectrometers. Since 2000 Oliver initiated the development of orthogonal time of flight mass spectrometers as project manager and later from 2003 as research and development manager for orthogonal time of flight mass spectrometer. The Bruker micrOTOF, micrOTOF-Q (1st commercial TOF making use of an ion funnel), maXis, impact and compact products have been developed in his department.
Since 2010 Oliver Raether leads the development of the timsTOF product series.
Oliver Raether has co-authored 14 peer reviewed publications and is inventor/co-inventor of 20 patent families with 71 patents in the field of mass spectrometry (h-index 13).

Mr. Oliver Raether

Click To Read Bio

Dr. Ole Vorm

Categories: Award Winners, Main Congress Speakers
Dr. Ole Vorm: Denmark
Ole Vorm has worked with mass spectrometry of proteins since the late 1980’s and received his PhD from the University of Southern Denmark in 1995 after working in the labs of Prof. Peter Roepstorff and Prof. Matthias Mann. After a brief post.doc appointment at the EMBL in Heidelberg, Dr Vorm founded one of the worlds first dedicated proteomics companies, Protana in 1997 and joined MDS Proteomics in 2000 as it acquired Protana. In 2004 Dr. Vorm founded Proxeon that was acquired in 2010 by Thermo Fisher Scientific and from 2014 to 2016 Dr. Vorm served as VP of Proteomics at Bruker Inc. In March 2016, Dr. Vorm founded Evosep, in order to continue to work on ruggedising and simplifying sample handling and separation in connection with mass spectrometry. Dr. Vorm is a firm believer that proteomics will become a cornerstone of precision medicine in the near future and is working to contribute to the necessary technology components.

Dr. Ole Vorm

Click To Read Bio

Dr. Melvin Park

Categories: Award Winners, Main Congress Speakers
Dr. Melvin Park: USA

Dr. Melvin Park is Director of Research at Bruker Daltonics. He received his bachelor’s degrees in Chemistry and Physics from NC State University in 1986 and a Ph.D. in Chemistry from Texas A&M in 1991. His dissertation centered on secondary ion mass spectrometry, coincidence counting, and time-of-flight mass spectrometry, and their application to surface analysis. After postdoctoral studies at the Naval Research Laboratories in 1993 regarding MALDI TOF, he joined Bruker. Over the past nearly three decades he and his colleagues have produced more than 80 issued patents and 30 peer reviewed journal articles in all areas of mass spectrometry and, more recently, ion mobility spectrometry. The most well-known of these is trapped ion mobility spectrometry (TIMS). His current work is the continued advancement and application of mass spectrometry, TIMS, and their peripherals.

Dr. Melvin Park

Click To Read Bio

Dr. Karin Rodland

Categories: Award Winners, Main Congress Speakers
Dr. Karin Rodland: USA
Dr. Karin Rodland joined the Biological Sciences Division at the Pacific Northwest National Laboratory in October 2001, after serving seventeen years on the faculty of Oregon Health Sciences University. As Chief Scientist for Biomedical Research at PNNL, she promoted the application of PNNL’s traditional strengths in mass spectrometry, proteomics, and systems biology to important problems in biomedical research. She served as the founding Director of the OHSU-PNNL Precision Medicine Innovation CoLaboratory, a joint effort dedicated to improving patient outcomes through the integration of cutting edge technologies in integrated omics, imaging, and data analysis to advance the goals of precision medicine.
Dr. Rodland’s own research focuses on signal transduction pathways that regulate proliferation in normal and malignant cells. Since joining PNNL, she has adopted a systems biology approach to signal transduction and has become a recognized expert in the field of proteomics and cancer biomarkers. She is a full member of the National Cancer Institute’s Early Detection Research Network and the Clinical Proteomics Tumor Analysis Consortium . She has served as Chair of the Cancer Biomarkers Study Section for the NIH, as well as the Department of Defense Congressionally Directed Medical Research Program Integration Panels for both Ovarian and Breast Cancer Research.

Dr. Karin Rodland

Click To Read Bio

Dr. Ben Collins

Categories: Award Winners, Main Congress Speakers
Dr. Ben Collins: Ireland

Since 2019 Ben is a Reader (equiv. Assoc. Prof.) in the the School of Biological Sciences, Queen’s University of Belfast, UK. His research focuses on broadly on 3 topics: (i) method development and applications in data independent acquisition mass spectrometry; (ii) method development and applications in the analysis of protein interaction networks and protein complexes; and (iii) applications of these strategies in host-pathogen biology and innate immunity. Ben’s PhD was completed at University College Dublin in 2009 where he remained for 1 year as the Agilent Technologies Newman Fellow (postdoctoral) in Quantitative Proteomics. Ben moved to the Institute of Molecular Systems Biology at ETH Zurich in Autumn 2010 as postdoctoral researcher under the supervision of Prof. Ruedi Aebersold, where his research focused on the application of quantitative interaction proteomics in signaling and the development of DIA/SWATH mass spectrometry. Following this Ben was a Group Leader and SNF Ambizione Fellow at IMSB, ETH Zurich with a focus on applying methods developed as a postdoc to relevant problems in host-pathogen biology.

Dr. Ben Collins

Click To Read Bio

Pre-Congress Speakers

Steve Pennington

Categories: Award Winners, Main Congress Speakers
Steve Pennington: Ireland

Steve is Professor of Proteomics at the UCD School of Medicine & Conway Institute in Dublin, Ireland. He graduated from Imperial College, London (Chemistry and Biochemistry) before completing a PhD in Biochemistry at the University of Cambridge. He was elected President of HUPO (www.hupo.org) (2019-2021) and recently received HUPO’s biennial distinguished service award. He is also the founder of the UCD spin out company Atturos (www.atturos.com).

Steve Pennington

Click To Read Bio

Prof. Ying Ge

Categories: Award Winners, Main Congress Speakers
Prof. Ying Ge: USA

Dr. Ying Ge is a Professor in the Department of Cell and Regenerative Biology and Department of Chemistry at University of Wisconsin-Madison. She received a B.S. from Peking University and a Ph.D. from Cornell University under the joint supervision of Prof. Fred McLafferty and Prof. Tadhg Begley. After graduate school, Dr. Ge explored a career in pharmaceutical industry. In 2012, Dr. Ge started her tenure-track Assistant Professor position, received tenure in 2015, and was promoted to Full Professor in 2019. Ge’s research is highly interdisciplinary that cuts across the traditional boundaries of chemistry, biology, and medicine. It is her belief that to make significant impact in molecular medicine, it is necessary to combine technology with function and bridge the silos between basic and translational/clinical research for precision medicine. Dr. Ge has devoted her past twenty years to developing and applying top-down mass spectrometry-based proteomics to biomedical research. Recently her lab has developed a multi-pronged approach to address the challenges in top-down proteomics. Dr. Ge has published over 150 papers with many in high impact journals. She has received a number of awards such as the ASMS Biemann Medal (2020), HUPO Clinical and Translational Proteomics Award (2021), and HPLC Society Georges Guiochon Faculty Fellowship (2016), as well as The Top 100 Analytical Scientist Power List (on a global scale, 2019, 2020 2021). Dr. Ge is passionate about education and has been mentoring students from chemistry, biology and medicine.

Prof. Ying Ge

Click To Read Bio

Prof. Tadashi Yamamoto

Categories: Award Winners, Main Congress Speakers
Prof. Tadashi Yamamoto: Japan
Prof. Tadashi YAMAMOTO, the project leader of the Biofluid Biomarker Center (BBC), is a pioneer of proteomics of kidney diseases and urine biomarker discovery after engaging in the HUPO Human Kidney & Urine Proteome Project (HKUPP) in 2005. During his HKUPP chairmanship he introduced proteomics in nephrology and provided proteomics information in nephrology through the HKUPP website. He and BBC group have developed the protocols for proteomics of formalin-fixed paraffin-embedded human kidney biopsy tissues to understand pathophysiology of kidney diseases and of urine to discover biomarkers of kidney and urinary tract diseases by providing a standard guide for urine collection, and urine and kidney tissue proteome databases. Recently the biomarker discovery has been extended to all human diseases In collaboration with Tosoh Corporation by collecting more than 100,000 urine samples from patients with any diseases. He and his group have established a standard protocol for urine quantitative proteomics to measure approximately 2,000 urine proteins quantitatively for discovery of urine biomarkers of all human diseases. His goal is to provide a healthcare system, called “All-in-One Urine Tests”, to people for easy checkup of health conditions and early detection of diseases only by urine examination at home or office.

Prof. Tadashi Yamamoto

Click To Read Bio

Prof. Fuchu He

Categories: Award Winners, Main Congress Speakers
Prof. Fuchu He: China

Dr. He is the leading scientist studying proteomics in China. He was the founder of CNHUPO and among the first group of people who founded HUPO in 2001. He was the first Chinese scientist who led an international consortium-Human Liver Proteome Project (HLPP), and the founder of Beijing Proteome Research Center, Phoenix Center (proteomics) and Institutes of Biomedical Sciences Fudan University. As the chief scientist, he has been propelling HLPP to the China Human Proteome Project (CNHPP), to create an encyclopedia of proteins in the human body under physiological and pathological conditions. In 2019, his team stratified early hepatocarcinoma (HCC) into 3 proteomic subtypes with different clinical outcome. Some drug targetable proteins have been demonstrated useful in identifying patients with HCC who could potentially benefit from targeted treatment in further clinical trials. These studies demonstrated the proteomic analysis as an independent powerful tool in cancer molecular subtyping, indicating that the era of “Proteomics Driven Precision Medicine (PDPM)” is coming. He is currently proposing a world-wide project called π-HuB (The Proteomic Navigator of the Human Body). It aims at playing a central and catalytic role in biomedical research over the next several decades and providing an ultimate solution at the molecular level for health and well-being of the humankind.

Prof. Fuchu He

Click To Read Bio

Prof. Benjamin Garcia

Categories: Award Winners, Main Congress Speakers
Prof. Benjamin Garcia: USA

Benjamin A. Garcia obtained his BS in Chemistry at UC Davis in 2000, and then received his PhD in Chemistry in 2005 at the University of Virginia under Prof. Donald Hunt and then was an NIH NRSA Postdoctoral Fellow at the University of Illinois under Prof. Neil Kelleher from 2005-2008. From there Ben was appointed as an Assistant Professor in the Molecular Biology Department at Princeton University from 2008-2012, until his recruitment as the Presidential Associate Professor of Biochemistry and Biophysics at the University of Pennsylvania Perelman School of Medicine in 2012, promoted to full Professor in 2016, and named the John McCrea Dickson M.D. Presidential Professor in 2017. Ben moved in the summer of 2021 to the Washington University School of Medicine in St. Louis to become the Chair of the Department of Biochemistry and Molecular Biophysics. The Garcia lab has been developing and applying novel proteomic approaches and bioinformatics for interrogating protein modifications, especially those involved in epigenetic mechanisms such as histones during human disease, publishing over 350 publications. Ben has also been recognized with many honors and awards for his mass spectrometry research including The ASMS Biemann Medal and was named a Fellow of the Royal Society of Chemistry.

Prof. Benjamin Garcia

Click To Read Bio

Nickki Packer

Categories: Award Winners, Main Congress Speakers
Nickki Packer: Australia

Prof Nicki Packer has had an extensive and varied research career in both Chemistry and Biological Sciences. She helped establish the Australian Proteome Analysis Facility (APAF) and co-founded Proteome Systems Ltd, a biotechnology company in which her group developed glycoanalytical technology and informatics tools. She has gained national and international recognition for her research in glycomics, using proteomics and bioinformatics approaches and linking it to biological functional research. Her current research is in the structure, function, informatics and application of glycans and their conjugates as molecular markers, focusing on their role in cancer, therapeutics and microbial infection. Nicki currently holds positions as Distinguished Professor of Glycoproteomics, and is a Chief Investigator in two ARC Centres of Excellence (NanoScale BioPhotonics and Synthetic Biology), is Academic Lead of APAF at Macquarie University, Sydney, and is a Principal Research Leader at the Institute for Glycomics, Griffith University, Australia. Her research role in all her work is directed towards the role of protein glycosylation in health and disease; specifically her current projects encompass the analysis and role of glycosylation in many systems including the i) function of glycans attached to glycoproteins and glycolipids, ii) cell membrane glycosylation interactions, iii) glycans as targets for bioimaging, diagnosis and drugs, iv) the mucin glycome-microbiome interactions. She has also raised three (reasonably well-balanced) children…..

Nickki Packer

Click To Read Bio

Mr. Oliver Raether

Categories: Award Winners, Main Congress Speakers
Mr. Oliver Raether: USA
Oliver Raether studied automation, measurement, control and feedback control engineering, optical- and environmental measurement and obtained in 1995 his Master of Science Degree from the Hamburg University of Technology in Germany.
In the same year Oliver Raether took up a position at Bruker Daltonik in Bremen Germany developing mobile gas chromatography and portable quadrupole mass spectrometers. Since 2000 Oliver initiated the development of orthogonal time of flight mass spectrometers as project manager and later from 2003 as research and development manager for orthogonal time of flight mass spectrometer. The Bruker micrOTOF, micrOTOF-Q (1st commercial TOF making use of an ion funnel), maXis, impact and compact products have been developed in his department.
Since 2010 Oliver Raether leads the development of the timsTOF product series.
Oliver Raether has co-authored 14 peer reviewed publications and is inventor/co-inventor of 20 patent families with 71 patents in the field of mass spectrometry (h-index 13).

Mr. Oliver Raether

Click To Read Bio

Dr. Ole Vorm

Categories: Award Winners, Main Congress Speakers
Dr. Ole Vorm: Denmark
Ole Vorm has worked with mass spectrometry of proteins since the late 1980’s and received his PhD from the University of Southern Denmark in 1995 after working in the labs of Prof. Peter Roepstorff and Prof. Matthias Mann. After a brief post.doc appointment at the EMBL in Heidelberg, Dr Vorm founded one of the worlds first dedicated proteomics companies, Protana in 1997 and joined MDS Proteomics in 2000 as it acquired Protana. In 2004 Dr. Vorm founded Proxeon that was acquired in 2010 by Thermo Fisher Scientific and from 2014 to 2016 Dr. Vorm served as VP of Proteomics at Bruker Inc. In March 2016, Dr. Vorm founded Evosep, in order to continue to work on ruggedising and simplifying sample handling and separation in connection with mass spectrometry. Dr. Vorm is a firm believer that proteomics will become a cornerstone of precision medicine in the near future and is working to contribute to the necessary technology components.

Dr. Ole Vorm

Click To Read Bio

Dr. Melvin Park

Categories: Award Winners, Main Congress Speakers
Dr. Melvin Park: USA

Dr. Melvin Park is Director of Research at Bruker Daltonics. He received his bachelor’s degrees in Chemistry and Physics from NC State University in 1986 and a Ph.D. in Chemistry from Texas A&M in 1991. His dissertation centered on secondary ion mass spectrometry, coincidence counting, and time-of-flight mass spectrometry, and their application to surface analysis. After postdoctoral studies at the Naval Research Laboratories in 1993 regarding MALDI TOF, he joined Bruker. Over the past nearly three decades he and his colleagues have produced more than 80 issued patents and 30 peer reviewed journal articles in all areas of mass spectrometry and, more recently, ion mobility spectrometry. The most well-known of these is trapped ion mobility spectrometry (TIMS). His current work is the continued advancement and application of mass spectrometry, TIMS, and their peripherals.

Dr. Melvin Park

Click To Read Bio

Dr. Karin Rodland

Categories: Award Winners, Main Congress Speakers
Dr. Karin Rodland: USA
Dr. Karin Rodland joined the Biological Sciences Division at the Pacific Northwest National Laboratory in October 2001, after serving seventeen years on the faculty of Oregon Health Sciences University. As Chief Scientist for Biomedical Research at PNNL, she promoted the application of PNNL’s traditional strengths in mass spectrometry, proteomics, and systems biology to important problems in biomedical research. She served as the founding Director of the OHSU-PNNL Precision Medicine Innovation CoLaboratory, a joint effort dedicated to improving patient outcomes through the integration of cutting edge technologies in integrated omics, imaging, and data analysis to advance the goals of precision medicine.
Dr. Rodland’s own research focuses on signal transduction pathways that regulate proliferation in normal and malignant cells. Since joining PNNL, she has adopted a systems biology approach to signal transduction and has become a recognized expert in the field of proteomics and cancer biomarkers. She is a full member of the National Cancer Institute’s Early Detection Research Network and the Clinical Proteomics Tumor Analysis Consortium . She has served as Chair of the Cancer Biomarkers Study Section for the NIH, as well as the Department of Defense Congressionally Directed Medical Research Program Integration Panels for both Ovarian and Breast Cancer Research.

Dr. Karin Rodland

Click To Read Bio

Dr. Ben Collins

Categories: Award Winners, Main Congress Speakers
Dr. Ben Collins: Ireland

Since 2019 Ben is a Reader (equiv. Assoc. Prof.) in the the School of Biological Sciences, Queen’s University of Belfast, UK. His research focuses on broadly on 3 topics: (i) method development and applications in data independent acquisition mass spectrometry; (ii) method development and applications in the analysis of protein interaction networks and protein complexes; and (iii) applications of these strategies in host-pathogen biology and innate immunity. Ben’s PhD was completed at University College Dublin in 2009 where he remained for 1 year as the Agilent Technologies Newman Fellow (postdoctoral) in Quantitative Proteomics. Ben moved to the Institute of Molecular Systems Biology at ETH Zurich in Autumn 2010 as postdoctoral researcher under the supervision of Prof. Ruedi Aebersold, where his research focused on the application of quantitative interaction proteomics in signaling and the development of DIA/SWATH mass spectrometry. Following this Ben was a Group Leader and SNF Ambizione Fellow at IMSB, ETH Zurich with a focus on applying methods developed as a postdoc to relevant problems in host-pathogen biology.

Dr. Ben Collins

Click To Read Bio

Sponsored Content